VR Firms Psious and Oncomfort Selected for TMCx Spring 2017 Accelerator Program

The Texas Medical Center (TMC) Innovation Institute has begun the fourth installment of TMCx, an accelerator program for startups. 24 companies have been selected, two of which specialise in virtual reality (VR), Psious and Oncomfort.

TMCx is designed to meet the needs of startups at every stage, aiming to introduce their health IT applications to the Houston health care market with companies from around the world being selected. Psious is located in Barcelona, Spain, working with immersion therapy for mental health disorders. While Oncomfort has locations in Houston and Brussels, Belgium, utilising VR technology to help ease patients’ stress, pain and anxiety during their medical journey.


“The Texas Medical Center hosts more than eight million patient visits each year, with people coming to Houston from all over the world, so it is fitting that this new cohort includes the best of the best in digital health startups from several international locations,” said Erik M. Halvorsen, Ph.D., director of the TMC Innovation Institute. “Our mission is to help these startups connect their promising technology to the leading minds in medicine and business in our network.”

Through the TMCx accelerator program the startups are provided a practical curriculum to assist participating founders on their entrepreneurial path. Successful investors, entrepreneurs, subject-matter experts, industry professionals and hospital leaders guide each startup in the areas of intellectual property, product development, regulatory strategies, health policy, marketing, fundraising, contract negotiations and communications.

The 24 companies will present their final pitch to an audience of advisors, hospital stakeholders and investors as part of Demo Day on 8th June 2017.

For further VR news from around the world, keep reading VRFocus.